The Cancer Industry: Unraveling the Politics

Although the last decade has seen important developments in the care of cancer patients, Moss argues that there is little change in the disease's survival rates, and challenges the medical establishment's continued support of ``proven cures''--surgery, radiation and chemotherapy--and its refusal to fund research for nutrition-based, holistic and other therapies (including controversial laetrile). In this tough-minded updated version of his 1980 The Cancer Syndrome , Moss further charges that the dearth of research by cancer centers reflects the economic interests of board members drawn from carcinogen- and pollution-causing industries (tobacco, oil, chemicals), as well as of drug company executives. Also lambasted is the Food and Drug Administration for its allegedly obstructionist regulations regarding clinical testing. Photos not seen by PW. (Nov.)